Sanjay Bambhaniya · Jul 24, 2026

Manipal Health Enterprises IPO Review | APPLY or AVOID?

Mainboard Book Build Upcoming

Hospitals And Clinic

BSE, NSE

Price Band

₹560 - ₹590

Issue Size

₹9,275.22 Cr

Lot Size

Min. Investment

₹14,750

Live GMP ₹33

5.59% Est. Listing: ₹623

SIP Calc Compare

IPO Timeline

DRHP FILED March 23, 2026

OPEN July 29, 2026

CLOSE July 31, 2026

ALLOTMENT August 3, 2026

LISTING August 5, 2026

IPO DETAILS REVIEW GMP SUBSCRIPTION ALLOTMENT STATUS

Manipal Health Enterprises IPO Review

Manipal Health Enterprises Ltd. started in 2010. It operates in the Healthcare – Hospitals And Clinic industry and provides tertiary and quaternary care to its customers across India. This business is based in Bengaluru. This IPO review covers the main facts of the offer. It helps you decide if the issue fits your portfolio. Updated review will be available soon.

Strengths & Risks

Strengths

India's largest multispecialty hospital group

Presence across key metros

Recognized healthcare brand network

Advanced infrastructure medical technology

4 Strengths Competitive Edge

Financial Update

The company released its restated financial statements for the year ending March 31, 2026. Total revenue was ₹10,520.52 crore increased from ₹8,362.79 in previous year. The net profit for the same period was ₹916.52 crore decreased from ₹1,081.67 in previous year. Assets increased by 76.69% compared to the previous year. This trend should be carefully studied prior to any investment. Updated review will be available soon.

IPO Valuation

The upper price band is ₹590. This price leads to a Price-to-Earnings (P/E) ratio of 84.65. The average P/E for the industry is –. Updated review will be available soon.

IPO Objective

Company will use Offer proceeds to meet stated objectives:

Repayment of subsidiary debt

Acquisition of minority stake

General corporate purposes

Promoters & Lead Manager

Lead managers have strong capital market background

Ranjan Ramdas Pai, Manipal Global Health Services, Memg International Ltd., Kangto Investments Pte.Ltd., Imperius Healthcare Investments Pte.Ltd., and Kabru Investments Pte.Ltd. are the promoters.

Kfin Technologies Ltd. is the registrar.

Peer Comparison

Below is the comparison of the company with its listed peers using data from March 31, 2026. Updated review will be available soon.

Company Name	EPS (Basic)	EPS (Diluted)	NAV (₹ per share)	P/E (x)	RoNW (%)	Financial statements	Financial statements
Manipal Health Enterprises Ltd.	7.71	7.67	72.55		10.57	Consolidated	Consolidated
Apollo Hospitals Enterprise Ltd	135.04	134.94		66.15		Consolidated	Consolidated
Fortis Healthcare Ltd	13.80	13.80		70.22		Consolidated	Consolidated
Max Healthcare Institute Ltd	14.83	14.76		74.55		Consolidated	Consolidated

IPO Review & Analyst Rating

Updated review will be available soon.

Analyst Name	Recommendation
Overall	Mixed Reviews
–	–
–	–

Disclaimer: The information on the site is informational only. The contents of this blog are not financial advice. You should not invest in any stock market instrument without consulting your Financial advisor.

Sanjay Bambhaniya

Sanjay has 8+ years of experience in data-driven IPO insights. His expertise in digital marketing and web development complements his financial knowledge and helps him to develop effective fintech solutions. He is an entrepreneur and director who helps investors understand complex primary market trends in easy-to-understand IPO reports, news, and updates.

Discussion & Feedback

0 Comments

No comments yet. Be the first to share your thoughts!